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Abstract
Exosomes, the smallest subset of extracellular vesicles (EVs), have recently attracted
much attention in the scientific community. Their involvement in intercellular communica-
tion and molecular reprogramming of different cell types created a demand for a stringent
characterization of the proteome which exosomes carry and deliver to recipient cells. Mass
spectrometry (MS) has been extensively used for exosome protein profiling. Unfortunately,
no standards have been established for exosome isolation and their preparation for MS,
leading to accumulation of artefactual data. These include the presence of high-abundance
exosome-contaminating serum proteins in culture media which mask low-abundance exo-
some-specific components, isolation methods that fail to yield “pure” vesicles or variability
in protein solubilization protocols. There is an unmet need for the development of stan-
dards for exosome generation, harvesting, and isolation from cellular supernatants and for
optimization of protein extraction methods before proteomics analysis by MS. In this com-
munication, we illustrate the existing problems in this field and provide a set of recommen-
dations that are expected to harmonize exosome processing for MS and provide the
faithful picture of the proteomes carried by exosomes. The recommended workflow for
effective and specific identification of proteins in exosomes released by the low number of
cells involves culturing cells in medium with a reduced concentration of exosome-depleted
serum, purification of exosomes by size-exclusion chromatography, a combination of dif-
ferent protein extraction method and removal of serum-derived proteins from the final data-
set using an appropriate sample of cell-unexposed medium as a control. Application of this
method allowed detection of >250 vesicle-specific proteins in exosomes from 10 mL of cul-
ture medium.
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Introduction
Exosomes are a subset of extracellular vesicles (EVs) with a diameter ranging from 30 to
150nm that originate from an endocytic compartment of parent cells. Exosomes are formed
within multivesicular bodies (MVBs) via the process of inward invagination. MVBs contained
intraluminal vesicles fuse with the plasma membrane of the components in a parent cell,
releasing exosomes into extracellular space [1,2]. The topography of the exosome membrane
components and the content of their lumen resemble those of the parent cell [3]. This biogene-
sis process accounts for the importance of exosomes freely circulating in all body fluids as
potential surrogates of parent cells and as a “liquid biopsy” of the tissue containing these parent
cells. Recent interest in establishing exosome molecular profiles has led to an explosion of
methods for their isolation from supernatants of cells and/or various body fluids (reviewed by
Alvarez et al. [4] and Kalra et al. [5]). However, despite numerous methodologies introduced
for exosome isolation, no single standardized and validated method has emerged to date; the
issue is discussed in a review paper by Abramowicz et al. [6]. The nomenclature for EVs
remains undefined, and exosome identity or their distinction from other, larger EVs remains
unclear. Separation of exosomes from “contaminating” proteins present in cellular superna-
tants or body fluids used as sources of exosomes represents a major challenge because
camouflaging of low-abundant proteins by high-abundant proteins is a common problem in
mass spectrometry (MS). Another barrier to the characterization of isolated exosomes is their
poor or incomplete recovery due to vesicle aggregation or a loss of exosomes during isolation
procedures. These and other pitfalls of exosome isolation and proteomics workflows might
contribute to the biased interpretation of results, incomplete definition of exosome cargos or,
in the worst case, to a mistaken recognition of contaminants as bona fide components of exo-
somes [7,8].
The goal of this study was to identify and eliminate the “trouble spots” that often arise dur-
ing preparation of exosomes for the MS analysis. The multi-step process of sample collection,
exosome isolation, and extraction of exosome proteins for the subsequent MS analysis requires
special attention to reduce the risk of introducing experimental artifacts. These may include
cell culture media-derived contaminants, biofluid components masquerading as components
of the exosome cargo or protein losses occurring during exosome extraction for MS analysis.
Here, we consider steps that can be taken to harmonize experimental conditions to improve
the quality of proteomic analysis of exosomes and provide recommendations for optimization
of the detection of low abundance proteins that are true components of exosomes rather than
contaminating serum or plasma artifacts.
Results
Removal of fetal bovine serum from cell culture supernatants to be used for
exosome isolation
Cell culture media used for exosome harvest and isolation are usually supplemented with fetal
bovine serum (FBS). High abundant serum proteins such as bovine albumin and bovine EVs
are potential sources of “contaminants” and can lead to detection errors in subsequent MS
analyses. When the amino acid sequence of the 20 most commonly identified exosome pro-
teins deposited in the ExoCarta database [9] was analyzed (S1 Table), a high degree of similar-
ity (often >95%) between homologous proteins in human and bovine exosomes was revealed.
In fact, some proteins, including actin, elongation factor 1-α-1 or 14-3-3 protein zeta/delta
were indistinguishable in the two species, implying that some bovine and human proteins can-
not be differentiated by bioinformatics analysis of MS data. Indeed, when the raw MS/MS data
Proteomics and exosomes: Pitfalls and solutions
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registered for the exosome fraction were analyzed with the Mascot search engine using either
human or bovine protein databases, the analysis returned 131 proteins that were specifically of
bovine origin (i.e., putative components of FBS) and 170 proteins that were specifically human
(i.e., putative exosome components). However, there were 135 proteins identified in both the
bovine and human databases. These data showed that very high levels of homology of human
and bovine proteins exist and comprise a large set of potential exosome components (S1 Fig).
The absence of FBS in cell culture media would be expected to solve the above-described
problem of bovine artifacts. However, serum deprivation can markedly affect cell growth and
viability. To determine whether removal of FBS for the final 24 h of culture would decrease the
presence of bovine proteins in exosome-rich supernatants, seven different human head and
neck cancer (HNC) cell lines were cultured without FBS during the last 24 h of incubation. As
shown in Fig 1, this 24h-deprivation of FBS resulted in significant inhibition (approximately
33%) of viability in all seven cell lines, with UM-SCC6 and A-253 showing the greatest growth
suppression that exceeded 40% relative to the “standard” FBS-supplemented medium.
The widely used alternative is to use media supplemented with FBS depleted of bovine exo-
somes by (a) overnight ultracentrifugation (UC) of medium containing FBS at 100,000 × g
[10] or (b) by the use commercial exosome-depleted (ED) FBS. We compared the two
approaches for efficacy in eliminating bovine contaminants from media supplemented with
20% (v/v) standard (STD) FBS or commercial ED FBS; each FBS was used after UC or without
UC. Acetylcholinesterase (ACHE) activity and Western blot detection for CD63 were used to
detect the presence of bovine exosomes. Fig 2a shows that UC of STD media decreased ACHE
activity and CD63 marker by 50% only. On the other hand, ACHE activity and CD63 protein
were barely detectable in the ED medium either pre- or post-UC (Fig 2b), indicating that the
“contamination” with bovine exosomes could be substantially decreased using cell cultures
with ED FBS but not with STD FBS depleted of exosomes by UC. Moreover, Fig 2c shows that
ED FBS had a substantially lower protein content than STD FBS by Coomassie blue staining.
When cells cultured in media supplemented with ED FBS and STD FBS were compared, no
significant difference in growth of FaDu cells was detected (Fig 2d). The ED FBS content as
low as 1% in the medium did not significantly impair cell growth while decreasing the content
of bovine proteins in culture supernatants. However, culturing of cells in media supplemented
Fig 1. Effects of fetal bovine serum (FBS) on cell viability. The cell viability assessed for the panel of head and neck cancer cell lines cultured for 24 h
in a medium with 10% FBS or without FBS supplementation.
https://doi.org/10.1371/journal.pone.0205496.g001
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with 1% FBS impaired viability of certain cell types in longer experiments (48–72 h; data not
showed). Hence, FBS concentration lower than 5% could not be recommended as a general
solution.
Exosome isolation from supernatants of tumor cell cultures by size
exclusion chromatography
Exosomes released by FaDu cells were isolated from cell culture supernatants by size exclusion
chromatography (SEC). Fig 3a shows that exosomes, monitored by Western blots as CD63+,
Fig 2. Characteristics of exosome-depleted FBS. In (a) Quantification of exosomes present in the cell culture medium supplemented with STD FBS or
ED FBS at the input and in the post-UC fractions (supernatant and pellet) based on ACHE activity. In (b) Western blot of CD63 in the cell culture
medium either before (input) or after UC (supernatant); Ponceau S staining demonstrates the serum albumin content. In (c) Coomassie blue staining of
electrophoretically-separated proteins from standard (STD) and exosome-depleted (ED) FBS. In (d) Effects of supplementation with FBS on cell
viability; FaDu cells were cultured for 24 h in a medium supplemented with STD FBS, ultracentrifuged STD FBS (STD-UC) or ED FBS.
https://doi.org/10.1371/journal.pone.0205496.g002
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Fig 3. Exosome isolation by the size exclusion chromatography. In (a) representative immunoblot showing the distribution
of exosome markers (CD63, CD9, CD81) and high-abundance serum proteins (illustrated by Ponceau S staining) in the
successive SEC fractions of a FaDU culture medium. In (b) total protein concentrations (μg/uL) in the subsequent SEC
fractions. In (c) culture medium supplemented with 5% ED FBS and NOT co-cultured with cells was analyzed as in Panel A;
“E+” denotes exosome-containing positive control.
https://doi.org/10.1371/journal.pone.0205496.g003
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CD9+ or CD81+ vesicles, were eluted in fractions # 5–8 with a gradual decrease in the later
fractions. In the complementary Ponceau stain of proteins on nitrocellulose membranes,
the most intensive bands appeared in fractions # 8–16, as also confirmed by total protein
measurements (Fig 3b). When medium supplemented with ED FBS and not preconditioned
with cells was applied to the column, the total protein distribution was analogous, yet no
CD63+/CD9+/CD81+ particles were detected (Fig 3c). We concluded that exosomes were
present in SEC fractions # 5–8, with the highest exosome level in fraction # 5, as confirmed by
the particle size distribution and transmission electron microscopy imaging (S2 Fig). These
experiments showed that SEC concentrates exosomes in fraction #5 and the majority of serum
proteins elute in later fractions (# 8–16), enabling recovery of “clean” exosomes that are
depleted of bovine proteins.
Mass spectrometry analysis of proteins in the SEC fractions
The shotgun MS analysis was applied to identify exosome proteins in SEC fractions # 5–8 of
the cell culture supernatant from FaDu cells (proteins identified in each fraction are listed in
the S2 Table). In a parallel experiment, a portion of medium supplemented with 5% ED FBS
which was not in contact with cells (i.e., a background control sample) was processed and the
same fractions # 5–8 were analyzed by MS (S2 Table). Proteins identified only in fractions of
medium preconditioned with cells were considered exosome-specific, while proteins identified
in fractions of “fresh” medium (i.e., not incubated with cells) were considered to be serum-
derived. The results demonstrated that the highest number of exosomal proteins and the lowest
number of serum proteins were detected in factions # 5 and # 6 (Fig 4a). In contrast, fractions
#7 and #8 were enriched in proteins derived from FBS. The most favorable ratio of the exo-
some-specific to serum-derived proteins was found in fraction #5. At the same time, we noted
that among proteins identified in cell-unexposed (“fresh”) medium there were a few proteins
listed in ExoCarta as the most often identified exosome proteins; these included actin, throm-
bospondin-1, tubulin-α, heat shock protein (HSP)90-α, glyceraldehyde 3-phosphate dehydro-
genase, galectin-3-binding protein, α-2-microglobulin and albumin (Fig 4b). This mistaken
Fig 4. Mass spectrometry analysis of the selected SEC fractions # 5–8. In (a) the number of proteins identified by MS in each SEC fraction; the ratios of
putative exosome specific (red) and FBS serum-derived proteins (gray) in each fraction are shown. In (b) the overlap between the top hundred exosomal
proteins reported in the ExoCarta database and proteins detected in the “fresh” culture medium supplemented with ED FBS (SEC fractions # 5–8).
https://doi.org/10.1371/journal.pone.0205496.g004
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identification of putative FBS-derived proteins as exosome components indicates that “con-
tamination” of exosomes with serum proteins is a common problem in the field.
Extraction of exosome proteins for mass spectrometry
Four methods commonly used for the extraction of exosome proteins were subsequently com-
pared (Fig 5). Three methods (A, B and C) are based on detergent-free membrane disruption;
method A (freeze/thaw cycles) was used to generate data presented in the previous paragraph).
The fourth one (D) utilizes high concentrations of SDS to solubilize exosome membranes and
is followed by in-solution protein digestion on the surface of a filter (filter-aided sample prepa-
ration, FASP), which allows for removal of components interfering with MS measurements.
The same sample of exosomes corresponding to SEC fraction # 5 (containing about 400ng of
protein) was divided into four equal portions and processed in parallel using the abovemen-
tioned methods. Surprisingly, qualitative and quantitative differences in the exosome content
were visible already on the LC chromatograms of tryptic digests (Fig 5a) and were confirmed
by the final results of the MS analysis. The list of proteins identified in each (sub)sample is pre-
sented in S3 Table. Significant differences in the number of identified proteins were noted in
samples processed by different methods. Sonication (Method B) was found to be the least
effective extraction method based on the number of detected proteins, whereas acetonitrile
treatment (Method C) was the most effective, allowing for detection of nearly 200 proteins
(Fig 5b). Comparisons of samples A, C and D showed that 123 proteins were present in all
three samples and 99 were “method-specific” proteins (Fig 5c). The Venn diagrams in Fig 5d
indicate that similar subsets of proteins detected in A, B, C and D samples overlapped with the
ExoCarta list of 100 most commonly reported exosome proteins. About 50% of proteins listed
in the ExoCarta were detected in each sample (S4 Table). The functional enrichment analysis
(Fig 5e) using the FunRich V3 database showed that in each sample over 80% of proteins were
exosome-related. Hence, there was no clear evidence that any of the four methods favored
detection of exosome-related proteins. However, the presented results demonstrate that the
final list of identified exosome proteins is strictly dependent on the method of protein extrac-
tion performed during sample preparation for MS.
Discussion
The emerging role of exosomes in intercellular communication and their potential involve-
ment in human health and disease has led to rapid development of methods for exosome isola-
tion and characterization. MS has been extensively used for protein profiling of exosomes
[11,12]. Numerous reports in the literature have provided lists of exosome proteins which are
contained in the ExoCarta database [9]. In most cases, these proteins were identified by MS
performed with exosomes obtained from different sources and isolated by various methods.
However, while immune-based methods, such as Western blots, allow for the detection in exo-
somes of very low-abundant protein species such as cytokines, MS often fails to detect them.
This may be because high-abundant proteins co-isolated with exosomes can mask low-abun-
dant exosome proteins, limiting their detection and identification. Furthermore, “contaminat-
ing” plasma or serum proteins create a background noise or are taken as bona fide exosome
components. The fact that protein species known to be serum components are present in exo-
some protein databases supports this conclusion. Albumin, an abundant serum component,
was originally classified by Lo¨tvall et al. [13] as an extracellular protein associated with and co-
isolating with exosomes. Others considered it as a non-specific serum-derived “contaminant”
[14]. In exosomes derived from serum or plasma, albumin is commonly used as a negative
“purity” marker [15,16]. Another example is β-actin, a protein reported by some researchers to
Proteomics and exosomes: Pitfalls and solutions
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Fig 5. A comparison of four different methods for exosome protein extraction. In (a) the LC profiles of exosome
samples processed by each of the four methods. In (b) numbers of exosome proteins identified by MS in each sample. In (c)
overlapping and distinct proteins identified using Methods A, C and D. In (d) numbers of exosome proteins overlapping
with or distinct from the ExoCarta database. In (e) functional enrichment analysis showing the percentages of the detected
proteins that were exosome-related in each method.
https://doi.org/10.1371/journal.pone.0205496.g005
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be enriched in exosomes [2,17], while others do not confirm its enrichment [14] or even use it
as a negative “purity” marker for exosomes [18,19]. Including such controversial proteins in
ExoCarta might be questionable and might be a result of many potential pitfalls in exosome
harvest, isolation, and processing in preparation for MS.
Most of the data on tumor-derived exosomes resulted from studies with cell lines cultured
in the presence of FBS. While the use of exosome-depleted FBS for the culture of these cell
lines is commonly practiced, most investigators may not be aware that ultracentrifugation at
100,000 × g for 24 h performed in their own laboratories carries the risk of only partial removal
of exosomes from FBS, leaving behind exosomes carrying bovine proteins. This is a serious
problem since proteins in FBS have more than 95% of sequence homology with human serum
proteins and cannot be differentiated by bioinformatics filtration. Our comparative analysis of
amino acid sequences of human and bovine serum proteins that are present on the list of 100
most commonly recorded exosome proteins in ExoCarta detected high level of similarity or, in
some cases, identity. Such conserved proteins are unlikely to be distinguished by MS as human
or bovine and are likely to be included in the final protein score, creating an artifact. Neverthe-
less, processing of cell-unexposed medium as a control sample and identification of serum-
derived components before establishing a final list of proteins specific for cell-derived exosome
is highly recommended.
Isolation of exosomes from supernatants or plasma using SEC columns has been described
as a favorable method for obtaining “clean” exosomes [20–22]. SEC is now recognized as the
best method for decreasing background noise, serving as an extra purification step that allows
for separation of exosomes from most, but not all, serum proteins. Our data confirm exosome
enrichment in the early SEC fractions. Nevertheless, even these exosome-enriched fractions
contained non-exosome proteins, which although significantly reduced in their abundance
were not eliminated.
It appears that the method selected for protein extraction from isolated exosomes is critical
for reliable MS analysis. The same exosome preparation extracted by four different methods,
including extraction with SDS, gave quantitatively and qualitatively distinct protein profiles.
Based on the number of identifications, sonication proved to be the least effective method of
protein extraction, while acetonitrile treatment seemed to be the most effective. Comparisons
of samples extracted using different methods revealed a similar number of proteins (with
exception of the least effective sonication), yet different subsets of exosome proteins were
detected in each sample originating from the same source. Therefore, the choice of the protein
extraction method is a crucial decision, which can seriously affect the final results. However, a
comparison of different methods of proteins extraction before initiation of a project focused
on a specific subset of exosome components could be recommended.
Based on the results reported in this study, the following recommendations for exosome
harvesting, isolation, and solubilization for MS analyses should be considered (summarized in
Fig 6): (a) culture media used for exosome harvesting should be supplemented with exosome-
depleted FBS. However in-house depletion by ultracentrifugation is unreliable, as it does not
remove all bovine contaminants. The use of ED commercial FBS is preferred as a low protein
level in commercial ED FBS translates into lower background in MS; (b) bovine serum pro-
teins may interfere with MS, accounting not only for a high background but also for potential
artefacts due to high similarity in protein sequences between human and bovine proteins;
(c) SEC provides an extra purification step that greatly supports MS through the separation of
exosomes that elute in early fractions and before serum proteins present in later fractions. If
the ratio of “exosome-specific”/"contaminating” proteins is kept low, as in early SEC fractions,
the detection of low-abundance exosome proteins is facilitated; (d) the methods selected for
exosome protein extraction, whether based on freeze/thaw cycles, acetonitrile treatment or
Proteomics and exosomes: Pitfalls and solutions
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SDS solubilization, are equally suitable for MS studies of low-abundance exosome proteins.
However, exosome sonication is not recommended, as it yields fewer proteins than the other
three procedures. These recommendations, if stringently applied to all samples, are expected
to improve MS-based proteomic analyses of exosomes originating from cell cultures or body
fluids. MS remains an irreplaceable tool in proteomic studies of exosomes, and the correct
sample processing eliminating methodological hurdles will certainly increase the quality of MS
results.
Materials and methods
Cell culture
All cell lines except UM-SCC6 were purchased from ATCC as the Head and Neck Cancer
Panel (TCP-1012). FaDu (HTB-43) and Detroit562 (CCL-138) cells were cultured in MEM
with Earle’s Salts (Sigma-Aldrich, 51412C) supplemented to the final concentration of 1 mM
Sodium Pyruvate (HyClone, SH30239.01), 2 mM L-glutamine (Biowest, X0550) and 1X MEM
non-essential amino acid solution (Sigma-Aldrich, M7145). SCC-9 (CRL-1629), SCC-15
(CRL-1623), SCC-25 (CRL-1628) were cultured in DMEM/F12 (HyClone, SH30023.02) sup-
plemented with Hydrocortisone 50 μg/mL (Sigma-Aldrich, H0135). A-253 (HTB-41) cells
were cultured in McCoy’s 5A (HyClone, SH30200.02). The UM-SCC6 cells were authenticated
with STR-based method and then cultured in DMEM (Sigma-Aldrich, D6429) supplemented
with 1x MEM non-essential amino acid solution. The final concentration of non-heat inacti-
vated FBS (HyClone, SH30088.03) for all culture media was 10% (v/v) with gentamicin at 0.16
mg/mL. The medium was replaced 3 times per week, and cells were incubated at 37˚C, in the
air with 5% CO2. Cells between passages 8–16 were harvested. For comparative studies and for
exosome isolation, cultures were supplemented with non-heat inactivated exosome-depleted
(ED) FBS (Gibco, A2720801).
Cell viability
Cell viability was assessed using CellTiter 96 Aqueous One Solution Reagent (Promega,
G3582). The absorbance of colored formazan, a bioconversion product of 3-(4,5-dimethylthia-
zol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium was measured at
490 nm using a 96-well plate reader (BioTek, Epoch). Cell suspensions containing 5 × 103–
1 × 104 cells/100 μL were plated in wells of a 96-well cell culture plate (Greiner Bio-One,
655180) and incubated for 48h. Then, the culture medium was replaced with fresh medium
supplemented with a pre-defined dose of standard (STD) FBS (HyClone) or exosome-depleted
(ED) FBS (Gibco). Cells were cultured for 24 h or 48 h. Next, the medium was removed and
Fig 6. Practical hints for effective proteomics analysis of exosomes.
https://doi.org/10.1371/journal.pone.0205496.g006
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replaced with the MTS substrate in serum-free medium containing phenol red. Measurements
were made every 20–30 min during a 3 h incubation in 5% CO2 in air at 37˚C.
Acetylcholinesterase activity assay
Acetylcholinesterase activity was measured in each ultracentrifugation-derived fraction diluted
5x with PBS. A 50 μL aliquot of each sample was added to wells of a 96-well flat-bottom micro-
plate (Greiner Bio-One, 655101). Serial dilutions of acetylcholinesterase (0 to 300 mU/mL)
were used as standards. Immediately before measurement, a 50 μL aliquot of the reaction mix-
ture (0.2 mM 5,50-dithiobis(2-nitrobenzoic acid) and 2.5 mM acetylthiocholine) was added to
each well, and the change in absorbance at 412 nm was measured after 20 min incubation.
Electrophoresis and protein immunodetection
Proteins were mixed with a loading buffer (12% SDS, 0.6% bromophenol blue, 60% glycerol,
and optionally 600 mM DTT) at the v/v ratio of 1:5 and denatured for 5min at 95˚C. Separa-
tion was performed using 11% home-made polyacrylamide gels. After the sample transfer (100
V, 60 min), nitrocellulose membranes (Thermo Scientific, 88018) were blocked for 1 h at RT
(5% non-fat dry milk in 150 mM NaCl, 10 mM Tris pH 7.5, 0.1% Tween-20) and incubated
overnight with a primary antibody (anti-CD63: Invitrogen, 10628D, 1:1500; anti-CD81: Invi-
trogen, 10630D, 1:800; anti-CD9: Invitrogen, 10626D, 1:800). After a triple wash (150mM
NaCl, 10mM TRIS pH 7.5, 0.1% Tween-20) a secondary HRP-conjugated antibody (Themo
Scientific, 31430) was added for 1 h of incubation. Bands were detected using SuperSignal
West Femto Maximum Sensitivity Substrate (Thermo Scientific, 34095) diluted at the volume
ratio of 1:10 with washing buffer. CD63 and CD81 were detected under non-reducing condi-
tions. Visualization of proteins on nitrocellulose membranes or in polyacrylamide gels was
performed using Ponceau S reversible staining (Sigma, P7170) or PageBlue Protein Staining
Solution (Thermo Scientific, 24620), respectively. A Perfect Tricolor Protein Ladder (Eurx,
E3210-01) was used as a protein molecular weight marker.
Exosome isolation
Cells were cultured in T175 flasks (Greiner BioOne, 660175). 24 h before exosome harvest, cell
culture medium was replaced with fresh medium containing 5% (v/v) ED FBS. A day later, cell
culture medium containing released exosomes was collected, pre-cleared from the remaining
cells or cellular debris by a series of centrifugations at 200, 2000 and 10,000 × g for 2 × 10 and
30 min, respectively. The supernatant was filtered using a 0.22 μm syringe filter unit (Roth,
PA49.1). Exosome enrichment was achieved using a Vivacell 100 centrifugal device (100 kDa
molecular weight cut-off; Sartorius, VC1042). An exosome sample (1 mL) was loaded onto
ready-to-use size exclusion chromatography columns (Izon Science). Fractions (1 mL) were
eluted with PBS without divalent cations. The first fraction was collected right after the sample
had been loaded and the total of 24 mL was collected. Samples were stored at -80˚C until use.
Preparation of exosome-depleted cell culture medium
Cell culture medium was prepared according to the protocol of The´ry et al. [10]. Briefly,
medium complemented with all required nutrients and 20% (v/v) FBS was ultracentrifuged
overnight at 100,000 × g at 4˚C (SW28 Ti swinging-bucket rotor, Beckman Coulter). Then, the
collected supernatant was sterilized with the use of a 0.22-μm syringe filter and stored at 4˚C.
The desired concentration was obtained by diluting the complete medium without FBS.
Proteomics and exosomes: Pitfalls and solutions
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Exosome proteins extraction and sample preparation for mass
spectrometry analysis
Exosomes were extracted using four different methods. (A) freeze-thaw cycles; (B) sonication;
(C) acetonitrile treatment; (D) SDS treatment. For comparison of protein extraction efficiency,
the SEC fraction #5 (containing approximately 0.4 μg of protein) was divided into four equal
aliquots and processed as follows. Sample A was subjected to 10 freeze-and-thaw cycles, each
lasting for 1 min in liquid nitrogen and 3 min at 95˚C. Sample B was sonicated using Bioruptor
Plus for 20 cycles [30 sec ON/30 sec OFF]. Sample C was mixed with acetonitrile to the final
concentration of 50% (v/v), and after 45 min of incubation at RT with occasional vortexing,
acetonitrile was evaporated using a centrifugal vacuum concentrator. Sample D was mixed
with a lysis buffer (4% SDS, 100mM Tris/HCl pH 7.6, 0.1M DTT) in the volume ratio of 1:1
and incubated at 95˚C for 5 min. Subsequently, samples A-C were further processed using a
standard in solution digestion protocol. Briefly, 250 mM solution of ammonium bicarbonate
was added to each sample to reach the final concentration of 25 mM. The mixture was reduced
in the presence of 5 mM DTT for 15 min at 60˚C. After cooling to RT, alkylation was per-
formed by incubation with iodoacetamide (15 mM) in darkness for 30 min. An extra portion
of the reducing agent was added for an additional 15 min of incubation to avoid trypsin alkyl-
ation by the leftover alkylation agent. Next, all samples were treated with modified trypsin
(Promega, V5111) at the final concentration of 4 ng/μL per sample. Sample D was processed
according to a standard FASP protocol [23] with minor modifications. The denatured and
reduced protein extract was mixed with 8 M urea (Sigma, U5128) in 0.1 M Tris/HCl pH 8.5 in
the volume ratio of 1:4 ratio, loaded onto a Microcon YM-10 (Millipore, Cat. MRCPRT010)
filtration device and centrifuged for 20 min. After additional washing with the urea solution, a
50 μL aliquot of 50 mM iodoacetamide solution in 8 M urea solution was added, mixed at 600
rpm in a heat block for 1 min and incubated without mixing for 20 min at RT. Three steps of
washing with 100 μL of urea solution were performed before double rinsing with 150 μl of a
digestion buffer (25mM ammonium bicarbonate), each time followed with centrifugation at
14000 × g for 25 min. Then, 40 μL of trypsin in the digestion buffer was added onto the filter
membrane and mixed at 600 rpm for 1 min. All samples were digested in a humid chamber at
37˚C for 18h. Next day, sample D was centrifuged at 14,000 × g for 25 min to recover peptides
after digestion. Samples A-C, as well as the filtrate of sample D, were then stored at -80˚C until
mass spectrometry analysis.
Mass spectrometry analysis
Identification and quantitation of exosome proteins were performed using the Dionex Ulti-
Mate 3000 RSLC nanoLC System connected to QExactive Orbitrap mass spectrometer
(Thermo Fisher Scientific). Peptides derived from in-solution digestion were separated on a
reverse phase Acclaim PepMap RSLC nanoViper C18 column (75 μm × 25 cm, 2 μm granula-
tion) using acetonitrile gradient (from 4 to 60%, in 0.1% formic acid) at 30˚C and a flow rate
of 300 nL/min (for 230 min). The spectrometer was operated in data-dependent MS/MS mode
with survey scans acquired at a resolution of 70,000 at m/z 200 in MS mode, and 17,500 at m/z
200 in MS2 mode. Spectra were recorded in the scanning range of 300–2000 m/z in the posi-
tive ion mode. Higher energy collisional dissociation (HCD) ion fragmentation was performed
with normalized collision energies set to 25.
For proteins identification and quantitation, obtained raw files were analyzed by Proteome
Discoverer (PD), version 1.4.14 (Thermo Fisher Scientific). The identification of proteins by
PD was performed using both Sequest and the Mascot engines against the UniProt Complete
Proteome Set of Humans (123,619 sequences; the database access in March 2017) using the
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following parameters identical for both search engines: a tolerance level of 10 ppm for MS and
0.08 Da for MS/MS. Trypsin was used as the digesting enzyme, and two missed cleavages were
allowed. The carbamidomethylation of cysteines was set as a fixed modification, and the oxida-
tion of methionines was allowed as a variable modification. Identifications were validated
using Percolator node based on q-value with FDR 0.01 for both proteins and peptides. To per-
form protein quantitation, Precursor Ion Area Detector node was used, followed by data
export to Excel where normalization based on total ion current was done.
Statistical analysis
Functional-enrichment analysis for GO-terms was performed using FunRich v3.0 software
[24]. For annotation of identified proteins, the FunRich database was used. Enriched terms in
cellular components category were assessed by hypergeometric test and ranked by p-value
using FunRich. A p< 0.05 was considered significant. The UniProt identifiers were converted
to gene name using FunRich and UniProt Retrieve/ID mapping tools. The gene names were
used as an input for presented analyses of mass spectrometry data.
Supporting information
S1 Fig. A Venn diagram showing the overlap between proteins identified when mass spec-
trometry data from exosome studies were used to search for overlapping human and
bovine protein sequences.
(PDF)
S2 Fig. Characteristics of exosomes. (a) The size distribution profile of exosomes was deter-
mined by a Zetasizer Nano-ZS90 instrument (Malvern Instruments). Samples (60μL) were
analyzed immediately after isolation at the constant temperature (20˚C) with dedicated dispos-
able low-volume cuvettes (ZEN0118, Malvern). Data were acquired and analyzed using Mal-
vern Zetasizer Software 7.12. The dispersant refractive index was 1.330 (ICN PBS Tablets) and
equilibration time was set for 30 s. In single analysis 10 measurements with 10 runs in auto-
matic mode were performed and averaged. The results are displayed as particle size distribu-
tion by number. Presented graph shows results for fraction #5. (b) For visualization of vesicles
a 5 μL of exosomes suspension was loaded on a collodion-carbon coated copper grid (300
mesh). Negative staining was performed with 1% aqueous uranyl acetate. The air dried grids
were analyzed using transmission electron microscopy Tecnai G2 T12 Spirit BioTwin FEI.
TEM analysis was performed by Laboratory of Electron Microscopy, Faculty of Biology, Uni-
versity of Gdansk. Presented images show exosomes in fraction #5.
(PDF)
S1 Table. List of 20 most commonly reported exosomal proteins according to ExoCarta
database: The similarity between human and bovine amino acid sequences.
(XLSX)
S2 Table. List of proteins identified in individual fractions 5–8 of SEC separation.
(XLSX)
S3 Table. Exosome proteins identified depending on extraction method.
(XLSX)
S4 Table. The presence of exosome proteins listed in the ExoCarta in sample extracted by
four different methods.
(XLSX)
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